The Broadly Neutralizing DEV_K57 Antibody, Isolated from a Convalescent Patient, in Complex with the SARS-CoV-2 RBD
The continuous evolution of SARS-CoV-2 necessitates broadly neutralizing antibodies for robust therapeutics. In this study, we isolated 1824 single B cells from a COVID-19 convalescent donor and obtained 91 pairs of nucleotide sequences potentially encoding VH/VL domains. From this library, we generated and evaluated a...